Post-mortem interaction between methidathion and human serum albumin in blood

Yoshikazu Yamagishi1, Sayaka Nagasawa1,2, Hirotaro Iwase1,3

  • 1Department of Legal Medicine, Graduate School of Medicine, Chiba University.

Insights

Methidathion (DMTP) pesticide binds to human serum albumin (HSA) in blood. DMTP-tyrosine and DMTP-cysteinylproline adducts in HSA can serve as biomarkers for DMTP poisoning.

Area of Science:

  • Toxicology
  • Biochemistry
  • Analytical Chemistry

Background:

  • Methidathion (DMTP) is a widely used organophosphorus pesticide.
  • DMTP has been detected in clinical cases of accidental exposure and suicide.
  • DMTP concentration decreases in blood post-mortem, making free DMTP difficult to detect.

Purpose of the Study:

  • To investigate the binding of DMTP to human serum albumin (HSA).
  • To identify potential biomarkers for DMTP poisoning.
  • To understand DMTP degradation in post-mortem blood.

Main Methods:

  • Liquid chromatography quadrupole time-of-flight mass spectrometry (LC-Q/TOF-MS) was used to detect DMTP adducts in HSA.
  • In vitro experiments assessed DMTP binding to HSA residues.
  • Analysis of post-mortem blood from a DMTP ingestion victim.

Main Results:

  • DMTP preferentially binds to lysine (K), tyrosine (Y), and cysteinylproline (CP) residues of HSA.
  • DMTP-K, DMTP-Y, and DMTP-CP adducts increased dose-dependently in vitro.
  • DMTP-Y and DMTP-CP adducts were detected in post-mortem blood.

Conclusions:

  • DMTP-Y-adduct and DMTP-CP-adduct are potential biomarkers for DMTP poisoning.
  • DMTP-CP adduct concentration can help determine DMTP levels in post-mortem blood.
  • This study elucidates DMTP-HSA interactions and their toxicological implications.

Related Concept Videos

Factors Affecting Protein-Drug Binding: Patient-Related Factors01:29

Factors Affecting Protein-Drug Binding: Patient-Related Factors

Protein-drug binding, a pivotal aspect of pharmacokinetics, is subject to considerable variability influenced by an array of patient-related factors. The intricate interplay of age, individual differences, and pathological conditions significantly impact the binding dynamics and subsequent pharmacological effects.
Age stands as a key determinant in protein-drug binding. Neonates, characterized by low albumin content, experience heightened concentrations of unbound drugs such as phenytoin and...
Phase II Reactions: Methylation Reactions01:17

Phase II Reactions: Methylation Reactions

Methylation is a phase II biotransformation process involving the attachment of a methyl group to a substrate. Enzymes known as methyltransferases orchestrate this reaction.
The mechanism of methylation unfolds in two stages. The first stage sees a methyltransferase enzyme facilitating the transfer of a methyl group from S-adenosylmethionine (SAM) to the substrate, forming S-adenosylhomocysteine (SAH). The second stage involves further metabolism of SAH into homocysteine, which can be recycled...
Effect of Hepatic Disease on Pharmacokinetics: Pathophysiologic Assessment and Liver Function Test01:22

Effect of Hepatic Disease on Pharmacokinetics: Pathophysiologic Assessment and Liver Function Test

In clinical practice, the direct measurement of hepatic blood flow to evaluate liver function presents significant challenges due to the intricate and specialized nature of the necessary techniques. Consequently, healthcare professionals often rely on empirical estimates derived from thorough patient examinations and liver function tests to gauge liver health. Among the tools at their disposal, the Child–Pugh and MELD scoring systems stand out for their ability to categorize and assess the...